Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 7 August 2008, doi:10.1136/bmj.a716
Cite this as: BMJ 2008;337:a716
S Bhattacharya, professor of reproductive medicine1, K Harrild, medical statistician1, J Mollison, senior medical statistician2, S Wordsworth, senior research officer3, C Tay, consultant gynaecologist4, A Harrold, consultant gynaecologist5, D McQueen, consultant gynaecologist6, H Lyall, consultant gynaecologist7, L Johnston, research nurse1, J Burrage, research nurse6, S Grossett, research nurse5, H Walton, research nurse7, J Lynch, research nurse7, A Johnstone, research nurse4, S Kini, clinical research fellow4, A Raja, clinical research fellow4, A Templeton, professor of obstetrics and gynaecology1
1 Department of Obstetrics and Gynaecology, University of Aberdeen, Aberdeen AB25 2ZD, 2 Centre for Statistics in Medicine, University of Oxford, Wolfson College Annexe, Oxford, 3 Health Economics Research Centre, University of Oxford, Oxford, 4 Simpson Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, 5 Assisted Conception Unit, Ninewells Hospital, Dundee, 6 Falkirk and District Royal Infirmary, Falkirk, 7 ACS Unit, Ground Floor, Walton Building, Royal Infirmary, Glasgow
Correspondence to: S Bhattacharya s.bhattacharya{at}abdn.ac.uk
Design Three arm parallel group, pragmatic randomised controlled trial.
Setting Four teaching hospitals and a district general hospital in Scotland.
Participants Couples with infertility for over two years, confirmed ovulation, patent fallopian tubes, and motile sperm.
Intervention Expectant management, oral clomifene citrate, and unstimulated intrauterine insemination.
Main outcome measures The primary outcome was live birth. Secondary outcome measures included clinical pregnancy, multiple pregnancy, miscarriage, and acceptability.
Results 580 women were randomised to expectant management (n=193), oral clomifene citrate (n=194), or unstimulated intrauterine insemination (n=193) for six months. The three randomised groups were comparable in terms of age, body mass index, duration of infertility, sperm concentration, and motility. Live birth rates were 32/193 (17%), 26/192 (14%), and 43/191 (23%), respectively. Compared with expectant management, the odds ratio for a live birth was 0.79 (95% confidence interval 0.45 to 1.38) after clomifene citrate and 1.46 (0.88 to 2.43) after unstimulated intrauterine insemination. More women randomised to clomifene citrate (159/170, 94%) and unstimulated intrauterine insemination (155/162, 96%) found the process of treatment acceptable than those randomised to expectant management (123/153, 80%) (P=0.001 and P<0.001, respectively).
Conclusion In couples with unexplained infertility existing treatments such as empirical clomifene and unstimulated intrauterine insemination are unlikely to offer superior live birth rates compared with expectant management.
Trial registration ISRCT No: 71762042
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses